The immune response to many viral infections is characterized by induction of virus-specific humoral and/or cellmediated immunity. For poliovirus, the humoral immune response is considered to form the basis of protective immunity against viral infections in humans. Extensive characterization of this humoral response in mice has identified regions of the viral capsid recognized by neutralizing antibodies (4-6, 8, 15, 22-24, 26, 33-35) . A major component in the development of an effective humoral response is the immunological help provided by antigen-specific T-helper (Th) cells. CD4+ helper T lymphocytes recognize foreign antigen fragments (Th epitopes) in the context of self major histocompatibility complex class II molecules. Such Th epitopes are distinct from B epitopes or antibody-binding sites. It is therefore important to define the Th epitopes present on the viral capsid proteins. Although little is known about the Th response upon host exposure to poliovirus, the absence of an antibody response in athymic mice demonstrates its contribution to the development of an effective poliovirus-specific humoral response (14) . Recently, a Th epitope was identified in capsid protein VP1 of poliovirus serotype 1, Mahoney strain (PVM) (17) . The present study was undertaken to analyze more extensively the murine T-cell response to poliovirus. Several Th epitopes were identified in the VP1 capsid protein for different inbred strains of mice. Interestingly, most of the Th epitopes of VP1 identified were found to lie close to previously identified neutralizing antibody-binding sites.
MATERIALS AND METHODS
Cells and media. HeLa cells in suspension culture were maintained in Joklik's modified minimal essential medium supplemented with 5% horse serum (GIBCO). Virus stocks were stored and diluted in phosphate-buffered saline. T-lymphocyte cultures were maintained in RPMI 1640 supple-* Corresponding author. mented with 2-mercaptoethanol (5 x 10-5 M) and 2% normal mouse serum.
Virus propagation and purification. PVM was grown by infecting suspension HeLa cells with a virus stock grown at low multiplicity from a plaque derived by transfection of the infectious cDNA (25) . Virus was purified by banding on cesium chloride gradients, and virus concentration was estimated by determining the optical density at 260 nm and using an extinction coefficient of 7.7 optical density units per mg per ml (30) .
Preparation of viral antigens. Capsid proteins VP1, VP2, and VP3 were isolated by electroelution from sodium dodecyl sulfate-polyacrylamide gels (5) . The concentrations of the eluted proteins were estimated in polyacrylamide gels by the staining intensities of the bands relative to those of capsid protein standards of known concentrations. Synthetic peptides of VP1 sequences were synthesized with solidphase methods by using a Beckman 990b peptide synthesizer. Most of these peptides were used previously to identify neutralization epitopes in VP1 (6) . Peptides were dissolved in the culture media and used at a concentration of 10 ,uglml.
Immunization and T-lymphocyte isolation. BALB/c (H-2d), Immunological characterization of T-lymphocyte cultures. Monoclonal antibodies (MAb) against the CD4, CD8, and Thyl.2 markers on murine T cells were used to define the T-lymphocyte population. GK1.5 is a rat hybridoma specific for the L3T4 (CD4) marker (7) . MAb 3.155 is a CD8-specific rat hybridoma (31) . H013.4 is a mouse anti-Thyl.2 hybridoma (29) . Serial dilutions of the hybridoma culture supernatants were added, together with poliovirus (1 ,ug/ml), to the T-lymphocyte cultures. T-cell proliferation was assayed 3 days later by thymidine incorporation.
Prediction of Th epitopes in VP1 capsid protein. The primary amino acid sequence of VP1 capsid protein of PVM was used for prediction of Th epitopes. Sites of hydrophobic variation consistent with formation of amphipathic segments were determined by using the AMPHI algorithm (19) . Calculations used the Fauchere-Pliska hydrophilicity scale (9), a block length of 7, and an amphipathicity score threshold of 8. The occurrence of Rothbard-Taylor motifs also was analyzed in the amino acid sequence of VP1 by scanning the sequence for a charged or glycine residue followed by two or three hydrophobic residues and subsequently a polar, charged, or glycine residue (27) .
Nomenclature. By convention, each amino acid residue within the capsid proteins is designated by using a four-digit number with the first digit identifying the capsid protein and the last three identifying the residue number. Thus, amino acid residues 1 through 302 from VP1 are designated 1001 through 1302. munoblot) analysis, the sera from these mice appeared to contain antibodies only to VP1, suggesting that the specific immunization protocol used in these studies may preferentially elicit VP1-specific immune responses (data not shown). Thus, the low proliferative responses to VP2 and VP3 observed may be due to the early predominance of VP1 immune responses rather than to an absence of T epitopes in VP2 or VP3. Antibody blocking of in vitro lymphocyte proliferation in response to poliovirus. The effector population involved in the proliferative response was characterized by using MAb that recognize the Thyl.2, L3T4, and CD8 surface markers. LN cells from poliovirus-immunized BALB/c mice were cultured in vitro in the presence of virus and serial dilutions of the hybridoma supernatants and subsequently assayed for proliferation responses (Fig. 2) . Consistent with the hypothesis that the response is due to a population of T lymphocytes present in the culture, virus-specific proliferation was effectively blocked in the presence of the anti-Thyl.2 MAb at all dilutions. The Thyl.2 marker was found on the surface of all mature T cells, T-cell precursors, and thymocytes and not on that of B lymphocytes. T-cell proliferation was effectively inhibited by the anti-L3T4 MAb and not by the anti-CD8 MAb at the same concentrations, indicating that the effector population in the LN cells involved in the poliovirus-specific proliferative response is that of CD4-positive Th cells.
RESULTS

Antigen
VP1 sequences recognized by Th cells. The strength of the proliferative response observed upon stimulation with purified VP1 capsid protein allowed further identification of the contributing epitopes. T lymphocytes were isolated from virus-immunized BALB/c mice and cultured in vitro with synthetic peptides of VP1 sequences as the stimulating antigen (Fig. 3A) . These synthetic peptides are from differ- (12) . Consistent with the previous report (17) , peptide 12a (spanning VP1 amino acid residues 1100 to 1109) induced proliferative responses with SI of greater than 2. In addition, peptides 7, 11, and 14 (spanning VP1 sequences 1202 to 1221, 1222 to 1241, and 1007 to 1024, respectively) also induced strong proliferative responses. (Because there is no apparent sequence homology between peptides 7 and 11, the positive proliferative responses observed suggest that both peptides contain T epitopes.) The responses were titratable and were not observed with naive mice (data not shown). All other peptides reproducibly failed to induce T-cell proliferation in these assays. Thus, three regions in VP1 (residues 1007 to 1024, 1100 to 1109, and 1202 to 1241) appear to be recognized by virus-specific Th lymphocytes from BALB/c mice.
The VP1 synthetic peptides were also used in proliferation studies to identify the T epitopes induced in other inbred mouse strains upon exposure to poliovirus (Fig. 3B and C) . Similar to the response observed in BALB/c mice, poliovirus-specific T lymphocytes from C57BL/6 mice proliferated in response to antigen stimulation with peptides 7 and 11. In contrast, no proliferation was detected with either peptide 14, 12a, or 12b, nor with peptide 3, whose sequences overlap those of peptides 12a and 12b. However, peptides 2 (spanning residues 1061 to 1080) and 15 (spanning residues 1110 to 1120) consistently stimulated proliferation in the C57BL/6 cultures. Thus, although the exact regions differ from those observed in BALB/c mice (H-2d), C57BL/6 (H-2") T lymphocytes also recognize three regions from VP1 (spanning 1061 to 1080, 1110 to 1120, and 1202 to 1241) and the major proliferative response was also observed with peptide 7. A more diffuse response was observed in the bulk T-lympho- WCPRPPfAVAYYG a The amphipathic character of VP1 sequences was iteratively examined from the N-terminal glycine in blocks of seven amino acids. Amphipathic segments are denoted by the midpoint positions of the identified blocks. Thus, the predicted sites extend on each side for three residues. P or K indicates the presence of proline or lysine in the amphipathic segment.
* The angle describes the pitch of the helix that is predicted by the amphipathic segment. C The Rothbard-Taylor motifs present within these amphipathic segments are underlined. 1024) and 1 (spanning residues 1024 to 1040) elicited significant proliferative responses, suggesting the presence of a second T-epitope-rich region in the N terminus of VP1. In addition, the SI observed with peptide 3 was significantly above the background. The peptide 3 sequence overlaps those of peptides 12a and 12b. Thus, although the C3H/HeJ response is more dispersed among the peptides examined, regions similar to those recognized in BALB/c mice also appear to contain T epitopes recognized by these mice. Interestingly, in each of the mouse strains examined, multiple Th epitopes appeared to be present in the VP1 region surrounding residues 1202 to 1241.
Prediction of Th epitopes in VP1. Theoretical approaches have been used to identify putative Th epitopes. One approach is based on observations that previously identified T epitopes were highly amphipathic in character and predicts T epitopes within a specific amino acid sequence on the basis of the propensity of amino acid sequences to form amphipathic segments (19) . Examination of the VP1 sequence by using the AMPHI algorithm identified nine amphipathic segments which form seven potential T-epitope regions ( Table 1) . Eight of the predicted amphipathic segments were represented by the panel of synthetic peptides used in T-cell proliferation assays. Of these eight predicted segments, the synthetic peptides from six of these regions induced T-cell proliferative responses in at least one strain of mice examined; peptides from two of the predicted segments failed to induce proliferative responses (Fig. 4) . However, three of the epitopes observed were not predicted by any of these algorithms. Most noticeably, peptide 12a was not predicted by the AMPHI algorithm. Thus, no strong correlation between the T epitopes identified and those predicted solely on the basis of their amphipathic character was observed.
The predictive value of the amphipathic segments is increased by the presence of Rothbard-Taylor motifs within these segments (27) . These are tetramer or pentamer sequences with the general structure GXXZ or GXXXZ, where G is a glycine or charged residue, X is any hydrophobic residue, and Z is a glycine, charged, or polar residue. Examination of the VP1 sequence identified 12 tetramer and 4 pentamer sequences as Rothbard-Taylor motifs. Only two tetramer motifs (HFYD and GAAS) and one pentamer motif (RAVAY) were found to lie in amphipathic segments, which are represented by peptides 7, 11, and 9 (Table 1) . Although no T-cell responses were observed with peptide 9, it is interesting that the region represented by peptides 7 and 11 induced strong proliferative responses in all three strains of mice examined.
DISCUSSION
Poliovirus-specific Th lymphocytes were isolated from virus-immunized mice of different H-2 haplotypes. Strong proliferative responses were induced within these T-lymphocyte populations upon stimulation with either purified VP1 capsid protein or VP1 synthetic peptides. By using the synthetic peptides, the locations of new Th epitopes were identified. Broadly, peptides which are recognized by multiple H-2 haplotypes and appear to identify the major VP1 Th epitopes lie in three regions (Fig. 4) .
One region, upon stimulation with peptides, induced strong proliferative responses in these bulk T-cell cultures. This region surrounds residues 1202 to 1241 of VP1. The relative predominance of responses observed in all three haplotypes to peptides from this VP1 region may be due to several factors. The predominant response to peptide 7 observed in BALB/c and C57BL/6 mice suggests that an immunodominant T epitope is located within this region. In addition, the proliferative responses induced by peptides 7 and 11 in BALB/c and C57BL/6 mice and by peptides 6, 11, and 8 in C3H/HeJ mice demonstrate that multiple T epitopes reside within this region. It is possible that any one peptide derived from this highly antigenic region includes more than one T-cell epitope. Thus, T lymphocytes of different epitope specificities may have contributed to the peptide response observed. Characterization of poliovirus-specific T-cell clones will help clarify these issues.
Peptides from a second region, surrounding residues 1086 to 1120, induced proliferative responses in BALB/c, C3H/ HeJ, and C57BL/6 mice. A similar Th epitope, which was reported to be present only in BALB/c mice, was identified previously by using a nested set of synthetic peptides in the region from 1103 to 1115 (17 11 and 12a (when coupled to keyhole limpet hemocyanin) induce serotype-specific poliovirus-neutralizing antibodies in immunized rats and rabbits (6) . Thus, the T epitopes recognized by the three murine haplotypes appear to be coincident with previously defined neutralizing antigenic sites. In addition, although positive Th responses were observed with peptide 2 in C57BL/6 mice only, this peptide (coupled to keyhole limpet hemocyanin) also induces a neutralizing antibody response in rats and rabbits (6) . Thus, a T-cell epitope appears to be located within this neutralizing antigenic site. It is unknown whether a neutralizing antigenic site is present at the N terminus of VP1. However, significant antibody titers to this region of VP1 have been observed in human vaccinees (4a). Thus, major poliovirus B and T epitopes may be located in close physical proximity and similar linkages may be seen with the neutralizing epitopes identified in VP2 and VP3.
Previous studies, using synthetic peptides, have demonstrated that an antipeptide antibody response is enhanced by linkage of T epitopes to this peptide sequence (10, 11, 16, 21) . Similarly, studies have shown that neutralizing antigenic sites of other viruses contain both T-and B-cell epitopes (1, 11, 13, 20, 21) and suggest that an efficient antibody response is dependent on the existence of B-and T-cell determinants in close proximity on a single processed antigen fragment. However, the presence of T epitopes within specific neutralizing sites cannot be the sole factor in determining the antigenic spectrum of the humoral response. In mice, immunization with serotype 3 poliovirus strains induces an antibody response to neutralizing site 1 (VP1 region 1091 to 1104) that is immunodominant (14, (22) (23) (24) . This immunodominant antibody response is not observed upon immunization with serotype 1 poliovirus strains (8, 14, 23, 26) . The identification of T epitopes within neutralizing site 1 of a serotype 1 poliovirus indicates that the immunodominance observed in serotype 3 and not serotype 1 strains is not due to the presence or absence of T epitopes within this neutralizing site. Thus, additional factors must contribute to regulation of the relative immunogenicity of specific antigenic sites within the virus.
